{"url_path":"/sec/txmd/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/25743/0001213900-26-055081-index.html","accession_number":"0001213900-26-055081","cik":"0000025743","ticker":"TXMD","issuer_name":"TherapeuticsMD, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/25743/0001213900-26-055081-index.html","primary_entity_key":"0000025743","primary_entity_name":"TherapeuticsMD, Inc."},"word_count":116,"has_tables":true,"body_markdown":"** **\n\n**Item 1A. Risk factors**\n\n \n\nOur business, financial condition and operating results can be affected\nby a number of factors, whether currently known or unknown, including but not limited to those described in Part I, Item 1A of the 2025\n10-K/A Report under the heading “Risk Factors,” any one or more of which could, directly or indirectly, cause our actual financial\ncondition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any\nof these factors, in whole or in part, could materially and adversely affect our business, financial condition, operating results and\nstock price. There have been no material changes to our risk factors since the 2025 10-K/A Report."}